| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | ADVZ 2022-1 (EUR 175m) | Advanz Pharma Corp (fka Concordia Healthcare Corp) | | EMEA | Jan 19, 2022 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| ZON | 243.000 | 5.87 | Mar-99 | Ri. Rhwsihz | F3 | H- | Y+ | Orlgu | P | - | 99.00-99.25 | 539 | 5% | - | 16.20300 |
Tranche Comments 6.25 jp: Redemption: 2024-04-01; Registration: 144N/Lqp Y; Comments: WKZ175n(zhuiqcp bxin WKZ150n) zuh ib 475n 5% Nhx 2028 (EQ 4/24, 50/25/hux) iip 7EQ3nx NNE ZcnN/144N. O3/O-/O+. XN(icbz/O&R), IOu Ouxj/DN/MXM/ILX/Icbb/ZOQ. Iuic 99.00-99.25, ILD 99.25 uxcu (+/-0.125) bix zhhcp 175n, junc 99.375 / O+539 zu 0.5% 2/28; Deal Comments BBZ150w asn ha BBZ475w 5% dwi 4/01/2028. Use of Proceeds Bjzjwkr Xewqewkbj Gkwqekjk |
|
|
